Impact of time to diagnosis on the occurrence of cardiogenic shock in MIS-C post-COVID-19 infection
- PMID: 36607546
- PMCID: PMC9817434
- DOI: 10.1007/s12519-022-00681-8
Impact of time to diagnosis on the occurrence of cardiogenic shock in MIS-C post-COVID-19 infection
Abstract
Background: In multisystem inflammatory syndrome in children (MIS-C), diagnostic delay could be associated with severity. This study aims to measure the time to diagnosis in MIS-C, assess its impact on the occurrence of cardiogenic shock, and specify its determinants.
Methods: A single-center prospective cohort observational study was conducted between May 2020 and July 2022 at a tertiary care hospital. Children meeting the World Health Organization MIS-C criteria were included. A long time to diagnosis was defined as six days or more. Data on time to diagnosis were collected by two independent physicians. The primary outcome was the occurrence of cardiogenic shock. Logistic regression and receiver operating characteristic curve analysis were used for outcomes, and a Cox proportional hazards model was used for determinants.
Results: Totally 60 children were assessed for inclusion, and 31 were finally analyzed [52% males, median age 8.8 (5.7-10.7) years]. The median time to diagnosis was 5.3 (4.2-6.2) days. In univariable analysis, age above the median, time to diagnosis, high C-reactive protein, and high N-terminal pro-B-type natriuretic peptide (NT-proBNP) were associated with cardiogenic shock [odds ratio (OR) 6.13 (1.02-36.9), 2.79 (1.15-6.74), 2.08 (1.05-4.12), and 1.70 (1.04-2.78), respectively]. In multivariable analysis, time to diagnosis ≥ 6 days was associated with cardiogenic shock [adjusted OR (aOR) 21.2 (1.98-227)]. Time to diagnosis ≥ 6 days had a sensitivity of 89% and a specificity of 77% in predicting cardiogenic shock; the addition of age > 8 years and NT-proBNP at diagnosis ≥ 11,254 ng/L increased the specificity to 91%. Independent determinants of short time to diagnosis were age < 8.8 years [aHR 0.34 (0.13-0.88)], short distance to tertiary care hospital [aHR 0.27 (0.08-0.92)], and the late period of the COVID-19 pandemic [aHR 2.48 (1.05-5.85)].
Conclusions: Time to diagnosis ≥ 6 days was independently associated with cardiogenic shock in MIS-C. Early diagnosis and treatment are crucial to avoid the use of inotropes and limit morbidity, especially in older children.
Keywords: COVID-19; Delay in diagnosis; Heart failure; MIS-C; SARS-CoV-2.
© 2023. Children's Hospital, Zhejiang University School of Medicine.
Conflict of interest statement
No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.
Figures



Similar articles
-
Cardiogenic Shock Risk Score at Diagnosis of Multisystem Inflammatory Syndrome in Children: A Multicenter Study.Pediatr Cardiol. 2025 Mar 12. doi: 10.1007/s00246-025-03823-7. Online ahead of print. Pediatr Cardiol. 2025. PMID: 40069379
-
NT-proBNP course during MIS-C post-COVID-19: an observational study.Eur J Pediatr. 2024 Apr;183(4):1667-1674. doi: 10.1007/s00431-023-05353-x. Epub 2024 Jan 11. Eur J Pediatr. 2024. PMID: 38206397
-
Multisystem inflammatory syndrome in children: Inputs of BNP, NT-proBNP and Galectin-3.Clin Chim Acta. 2022 Apr 1;529:109-113. doi: 10.1016/j.cca.2022.02.011. Epub 2022 Feb 18. Clin Chim Acta. 2022. PMID: 35183528
-
Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.World J Pediatr. 2021 Aug;17(4):335-340. doi: 10.1007/s12519-021-00435-y. Epub 2021 May 20. World J Pediatr. 2021. PMID: 34013488 Free PMC article. Review.
-
Multisystem Inflammatory Syndrome in Children (MIS-C).Curr Allergy Asthma Rep. 2022 May;22(5):53-60. doi: 10.1007/s11882-022-01031-4. Epub 2022 Mar 22. Curr Allergy Asthma Rep. 2022. PMID: 35314921 Free PMC article. Review.
Cited by
-
Cardiogenic Shock Risk Score at Diagnosis of Multisystem Inflammatory Syndrome in Children: A Multicenter Study.Pediatr Cardiol. 2025 Mar 12. doi: 10.1007/s00246-025-03823-7. Online ahead of print. Pediatr Cardiol. 2025. PMID: 40069379
-
Clinical Significance of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Pediatric Patients: Insights into Their Utility in the Presence or Absence of Pre-Existing Heart Conditions.Int J Mol Sci. 2024 Aug 12;25(16):8781. doi: 10.3390/ijms25168781. Int J Mol Sci. 2024. PMID: 39201467 Free PMC article. Review.
-
Baseline Echocardiography and Laboratory Findings in MIS-C and Associations with Clinical Illness Severity.Pediatr Cardiol. 2024 Mar;45(3):560-569. doi: 10.1007/s00246-023-03394-5. Epub 2024 Jan 28. Pediatr Cardiol. 2024. PMID: 38281215
-
Progress on diagnosis and treatment of multisystem inflammatory syndrome in children.Front Immunol. 2025 Feb 19;16:1551122. doi: 10.3389/fimmu.2025.1551122. eCollection 2025. Front Immunol. 2025. PMID: 40046058 Free PMC article. Review.
-
Case Report: Two episodes of hyperinflammation in an infant consistent with multisystem inflammatory syndrome in children: recurrence or rather two different diseases?Front Pediatr. 2025 Jun 5;13:1559244. doi: 10.3389/fped.2025.1559244. eCollection 2025. Front Pediatr. 2025. PMID: 40538934 Free PMC article.
References
-
- SPF. Situation épidémiologique liée à la COVID-19 chez les 0–17 ans. Point au 7 juillet 2022. https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-.... Accessed 20 Aug 2022
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous